3/27
08:02 am
onc
BeOne Medicines (ONC) is now covered by Wolfe Research. They set an "outperform" rating and a $340.00 price target on the stock.
Low
Report
BeOne Medicines (ONC) is now covered by Wolfe Research. They set an "outperform" rating and a $340.00 price target on the stock.
3/27
08:02 am
onc
BeOne Medicines (ONC) is now covered by Wolfe Research. They set an "outperform" rating and a $340.00 price target on the stock.
Low
Report
BeOne Medicines (ONC) is now covered by Wolfe Research. They set an "outperform" rating and a $340.00 price target on the stock.
3/27
07:53 am
onc
Rating for ONC
Low
Report
Rating for ONC
3/27
07:53 am
onc
Rating for ONC
Low
Report
Rating for ONC
3/26
04:17 pm
onc
BeOne Medicines initiated with an Outperform at Wolfe Research
Low
Report
BeOne Medicines initiated with an Outperform at Wolfe Research
3/26
04:17 pm
onc
BeOne Medicines initiated with an Outperform at Wolfe Research
Low
Report
BeOne Medicines initiated with an Outperform at Wolfe Research
3/16
08:55 am
onc
Rating for ONC
Low
Report
Rating for ONC
3/16
08:55 am
onc
Rating for ONC
Low
Report
Rating for ONC
3/16
05:22 am
onc
BeOne Medicines downgraded to Hold from Buy at Jefferies
Low
Report
BeOne Medicines downgraded to Hold from Buy at Jefferies
3/16
05:22 am
onc
BeOne Medicines downgraded to Hold from Buy at Jefferies
Low
Report
BeOne Medicines downgraded to Hold from Buy at Jefferies
2/27
12:41 pm
onc
Rating for ONC
Low
Report
Rating for ONC
2/27
12:41 pm
onc
Rating for ONC
Low
Report
Rating for ONC
2/27
10:45 am
onc
Rating for ONC
Low
Report
Rating for ONC
2/27
10:45 am
onc
Rating for ONC
Low
Report
Rating for ONC
2/27
10:06 am
onc
Rating for ONC
Low
Report
Rating for ONC
2/27
10:06 am
onc
Rating for ONC
Low
Report
Rating for ONC
2/26
05:03 pm
onc
BeOne Medicines (ONC) had its "outperform" rating reaffirmed by Royal Bank Of Canada.
Low
Report
BeOne Medicines (ONC) had its "outperform" rating reaffirmed by Royal Bank Of Canada.
2/26
05:03 pm
onc
BeOne Medicines (ONC) had its "outperform" rating reaffirmed by Royal Bank Of Canada.
Low
Report
BeOne Medicines (ONC) had its "outperform" rating reaffirmed by Royal Bank Of Canada.
2/4
08:57 am
onc
Rating for ONC
Low
Report
Rating for ONC
2/4
08:57 am
onc
Rating for ONC
Low
Report
Rating for ONC
2/4
06:09 am
onc
BeOne Medicines (NASDAQ:ONC) had its "overweight" rating reaffirmed by analysts at Barclays PLC.
Low
Report
BeOne Medicines (NASDAQ:ONC) had its "overweight" rating reaffirmed by analysts at Barclays PLC.